Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Feb 19, 2026
Sale
Shares
1,059
Price
$475.09
Total Value
$503.12K
Shares Held After
42,343
% of Holdings
2.4%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Feb 19, 2026
Sale
Shares
288
Price
$473.23
Total Value
$136.29K
Shares Held After
43,402
% of Holdings
0.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Feb 19, 2026
Sale
Shares
775
Price
$472.76
Total Value
$366.39K
Shares Held After
43,690
% of Holdings
1.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Feb 19, 2026
Sale
Shares
616
Price
$471.36
Total Value
$290.36K
Shares Held After
44,465
% of Holdings
1.4%
Feb 19, 2026
Purchase
Shares
1,200
Price
$9.60
Total Value
$11.52K
Shares Held After
259,992
% of Holdings
0.5%
Feb 18, 2026
Purchase
Shares
74,577
Price
$7.04
Total Value
$525.02K
Shares Held After
1,033,605
% of Holdings
7.2%

PULSE BIOSCIENCES, INC. (PLSE)

Danahy Kevin Patrick — Chief Commercial Officer
Feb 18, 2026
Sale
Shares
5,000
Price
$23.64
Total Value
$118.20K
Shares Held After
43,298
% of Holdings
10.4%
Feb 18, 2026
Sale
Shares
99,574
Price
$44.01
Total Value
$4.38M
Shares Held After
279,942
% of Holdings
26.2%
Feb 18, 2026
Sale
Shares
423
Price
$73.00
Total Value
$30.88K
Shares Held After
75,489
% of Holdings
0.6%

NEKTAR THERAPEUTICS (NKTR)

Zalevsky Jonathan — Chief R&D Officer
Feb 18, 2026
Sale
Shares
180
Price
$73.00
Total Value
$13.14K
Shares Held After
21,174
% of Holdings
0.8%

ALIGN TECHNOLOGY INC (ALGN)

Morici John — EVP, CHIEF FINANCIAL OFFICER
Feb 18, 2026
Sale
Shares
7,969
Price
$189.31
Total Value
$1.51M
Shares Held After
8,237
% of Holdings
49.2%
Feb 18, 2026
Purchase
Shares
10,658
Price
$17.48
Total Value
$186.30K
Shares Held After
10,658
% of Holdings
100.0%

PTC THERAPEUTICS, INC. (PTCT)

Gravier Pierre — CHIEF FINANCIAL OFFICER
Feb 18, 2026
Sale
Shares
2,992
Price
$69.36
Total Value
$207.53K
Shares Held After
87,318
% of Holdings
3.3%

PTC THERAPEUTICS, INC. (PTCT)

Golden Lee Scott — EVP & CHIEF MEDICAL OFFICER
Feb 18, 2026
Sale
Shares
2,484
Price
$69.36
Total Value
$172.29K
Shares Held After
89,944
% of Holdings
2.7%

PTC THERAPEUTICS, INC. (PTCT)

Pauwels Eric — CHIEF BUSINESS OFFICER
Feb 18, 2026
Sale
Shares
3,019
Price
$69.36
Total Value
$209.40K
Shares Held After
77,122
% of Holdings
3.8%

Septerna, Inc. (SEPN)

Bhatt Elizabeth — President and COO
Feb 18, 2026
Sale
Shares
1,800
Price
$29.58
Total Value
$53.25K
Shares Held After
174,209
% of Holdings
1.0%

Septerna, Inc. (SEPN)

Bhatt Elizabeth — President and COO
Feb 18, 2026
Sale
Shares
2,200
Price
$28.46
Total Value
$62.61K
Shares Held After
176,009
% of Holdings
1.2%
Feb 18, 2026
Sale
Shares
7,371
Price
$69.36
Total Value
$511.25K
Shares Held After
387,082
% of Holdings
1.9%

PTC THERAPEUTICS, INC. (PTCT)

Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Feb 18, 2026
Sale
Shares
65
Price
$69.36
Total Value
$4.51K
Shares Held After
6,726
% of Holdings
1.0%

PTC THERAPEUTICS, INC. (PTCT)

Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Feb 18, 2026
Sale
Shares
3,056
Price
$69.36
Total Value
$211.96K
Shares Held After
112,140
% of Holdings
2.7%

Lexeo Therapeutics, Inc. (LXEO)

Otero Jose Manuel — Chief Operating Officer
Feb 18, 2026
Sale
Shares
3,016
Price
$6.40
Total Value
$19.29K
Shares Held After
125,460
% of Holdings
2.3%

Annexon, Inc. (ANNX)

Overdorf Michael — EVP & CHIEF BUSINESS OFFICER
Feb 18, 2026
Sale
Shares
6,225
Price
$5.10
Total Value
$31.75K
Shares Held After
124,464
% of Holdings
4.8%
Feb 18, 2026
Sale
Shares
10,173
Price
$6.38
Total Value
$64.92K
Shares Held After
392,483
% of Holdings
2.5%

PTC THERAPEUTICS, INC. (PTCT)

Utter Christine Marie — SVP, CHIEF ACCOUNTING OFFICER
Feb 18, 2026
Sale
Shares
2,494
Price
$69.36
Total Value
$172.98K
Shares Held After
70,199
% of Holdings
3.4%

Annexon, Inc. (ANNX)

ARTIS DEAN RICHARD — EVP & CHIEF SCIENTIFIC OFFICER
Feb 18, 2026
Sale
Shares
5,290
Price
$5.10
Total Value
$26.98K
Shares Held After
123,487
% of Holdings
4.1%

HEALTHCARE SERVICES GROUP INC (HCSG)

Orr Patrick J — EVP & Chief Revenue Officer
Feb 18, 2026
Sale
Shares
33,448
Price
$20.52
Total Value
$686.35K
Shares Held After
0
% of Holdings
100.0%

HEALTHCARE SERVICES GROUP INC (HCSG)

Orr Patrick J — EVP & Chief Revenue Officer
Feb 18, 2026
Sale
Shares
11,167
Price
$20.55
Total Value
$229.48K
Shares Held After
33,448
% of Holdings
25.0%
Feb 18, 2026
Sale
Shares
1,157
Price
$3.34
Total Value
$3.86K
Shares Held After
91,019
% of Holdings
1.3%

Annexon, Inc. (ANNX)

Lew Jennifer — EVP & CHIEF FINANCIAL OFFICER
Feb 18, 2026
Sale
Shares
7,851
Price
$5.11
Total Value
$40.12K
Shares Held After
113,765
% of Holdings
6.5%

Annexon, Inc. (ANNX)

Yednock Ted — EVP & CHIEF INNOVATION OFFICER
Feb 18, 2026
Sale
Shares
7,857
Price
$5.11
Total Value
$40.15K
Shares Held After
97,227
% of Holdings
7.5%

ALX ONCOLOGY HOLDINGS INC (ALXO)

Pinto Shelly — SVP, FINANCE AND CAO
Feb 18, 2026
Sale
Shares
565
Price
$2.27
Total Value
$1.28K
Shares Held After
87,708
% of Holdings
0.6%

Keros Therapeutics, Inc. (KROS)

Regnante Keith — CHIEF FINANCIAL OFFICER
Feb 18, 2026
Sale
Shares
4,739
Price
$16.35
Total Value
$77.48K
Shares Held After
39,261
% of Holdings
10.8%

Annexon, Inc. (ANNX)

Dananberg Jamie — CHIEF MEDICAL OFFICER
Feb 18, 2026
Sale
Shares
5,290
Price
$5.10
Total Value
$26.98K
Shares Held After
73,152
% of Holdings
6.7%
Feb 18, 2026
Sale
Shares
3,882
Price
$3.44
Total Value
$13.35K
Shares Held After
206,196
% of Holdings
1.8%

Keros Therapeutics, Inc. (KROS)

Lerner Lorena Raquel — Chief Science Officer
Feb 18, 2026
Sale
Shares
3,873
Price
$16.35
Total Value
$63.32K
Shares Held After
31,127
% of Holdings
11.1%
Feb 18, 2026
Sale
Shares
1,376
Price
$3.34
Total Value
$4.59K
Shares Held After
682,000
% of Holdings
0.2%
Feb 18, 2026
Sale
Shares
5,990
Price
$3.34
Total Value
$19.99K
Shares Held After
1,046,055
% of Holdings
0.6%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Feb 18, 2026
Sale
Shares
1,276
Price
$79.97
Total Value
$102.04K
Shares Held After
0
% of Holdings
100.0%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Feb 18, 2026
Sale
Shares
3,026
Price
$79.16
Total Value
$239.53K
Shares Held After
1,276
% of Holdings
70.3%

Voyager Therapeutics, Inc. (VYGR)

Carter Todd Alfred — Chief Scientific Officer
Feb 18, 2026
Sale
Shares
3,301
Price
$3.44
Total Value
$11.36K
Shares Held After
149,892
% of Holdings
2.2%

ACCURAY INC (ARAY)

MAYER STEVEN F — Director
Feb 18, 2026
Purchase
Shares
126,125
Price
$0.53
Total Value
$67.20K
Shares Held After
1,421,745
% of Holdings
8.9%

Cencora, Inc. (COR)

Mauch Robert P. — Director
Feb 18, 2026
Sale
Shares
1,333
Price
$359.46
Total Value
$479.16K
Shares Held After
65,393
% of Holdings
2.0%

Keros Therapeutics, Inc. (KROS)

Cho Esther — SVP, General Counsel
Feb 18, 2026
Sale
Shares
4,745
Price
$16.35
Total Value
$77.58K
Shares Held After
39,755
% of Holdings
10.7%
Feb 18, 2026
Sale
Shares
11,732
Price
$3.41
Total Value
$40.01K
Shares Held After
498,257
% of Holdings
2.3%

Aveanna Healthcare Holdings, Inc. (AVAH)

Shaner Jeff — Chief Executive Officer
Feb 18, 2026
Sale
Shares
168,800
Price
$7.38
Total Value
$1.25M
Shares Held After
2,824,117
% of Holdings
5.6%

Aveanna Healthcare Holdings, Inc. (AVAH)

Buckhalter Matthew — Chief Financial Officer
Feb 18, 2026
Sale
Shares
13,167
Price
$7.38
Total Value
$97.21K
Shares Held After
542,755
% of Holdings
2.4%

Aveanna Healthcare Holdings, Inc. (AVAH)

Cunningham Patrick A. — Chief Compliance Officer
Feb 18, 2026
Sale
Shares
17,965
Price
$7.38
Total Value
$132.63K
Shares Held After
356,191
% of Holdings
4.8%

Aveanna Healthcare Holdings, Inc. (AVAH)

Stewart Deborah — SVP, Chief Accounting Officer
Feb 18, 2026
Sale
Shares
10,896
Price
$7.38
Total Value
$80.44K
Shares Held After
312,988
% of Holdings
3.4%

Aveanna Healthcare Holdings, Inc. (AVAH)

Reisz Edwin C. — Chief Administrative Officer
Feb 18, 2026
Sale
Shares
59,217
Price
$7.38
Total Value
$437.19K
Shares Held After
1,507,826
% of Holdings
3.8%
Feb 18, 2026
Sale
Shares
14,952
Price
$1.63
Total Value
$24.36K
Shares Held After
219,092
% of Holdings
6.4%
Version: v26.3.33